Another study explored the potential global role of p53 in the complex network of pathways and cell–cell interactions involved in mediating injury and local inflammation in chronic liver disease and NAFLD [77]. The gene discussed is TP53; the disease is metabolic dysfunction-associated steatotic liver disease.